TR200003157T2 - Abacavir, lamivudin ve zidovudin içeren homojen farmasötik bileşimler - Google Patents
Abacavir, lamivudin ve zidovudin içeren homojen farmasötik bileşimlerInfo
- Publication number
- TR200003157T2 TR200003157T2 TR2000/03157T TR200003157T TR200003157T2 TR 200003157 T2 TR200003157 T2 TR 200003157T2 TR 2000/03157 T TR2000/03157 T TR 2000/03157T TR 200003157 T TR200003157 T TR 200003157T TR 200003157 T2 TR200003157 T2 TR 200003157T2
- Authority
- TR
- Turkey
- Prior art keywords
- lamivudine
- zidovudine
- pharmaceutical compositions
- compositions containing
- abacavir
- Prior art date
Links
- LHCOVOKZWQYODM-CPEOKENHSA-N 4-amino-1-[(2r,5s)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one;1-[(2r,4s,5s)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)SC1.O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 LHCOVOKZWQYODM-CPEOKENHSA-N 0.000 title abstract 2
- 229960004748 abacavir Drugs 0.000 title abstract 2
- MCGSCOLBFJQGHM-SCZZXKLOSA-N abacavir Chemical compound C=12N=CN([C@H]3C=C[C@@H](CO)C3)C2=NC(N)=NC=1NC1CC1 MCGSCOLBFJQGHM-SCZZXKLOSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 3
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biophysics (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9809213.3A GB9809213D0 (en) | 1998-04-29 | 1998-04-29 | Pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200003157T2 true TR200003157T2 (tr) | 2001-01-22 |
Family
ID=10831228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2000/03157T TR200003157T2 (tr) | 1998-04-29 | 1999-04-26 | Abacavir, lamivudin ve zidovudin içeren homojen farmasötik bileşimler |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1083932A1 (pt) |
| JP (1) | JP2002512979A (pt) |
| KR (1) | KR20010043128A (pt) |
| CN (1) | CN1411380A (pt) |
| AP (1) | AP2000001971A0 (pt) |
| AU (1) | AU4135599A (pt) |
| BR (1) | BR9910071A (pt) |
| CA (1) | CA2330391A1 (pt) |
| EA (1) | EA200000997A1 (pt) |
| EE (1) | EE200000646A (pt) |
| GB (1) | GB9809213D0 (pt) |
| HR (1) | HRP20000732A2 (pt) |
| HU (1) | HUP0101622A3 (pt) |
| ID (1) | ID26955A (pt) |
| IL (1) | IL139181A0 (pt) |
| IS (1) | IS5675A (pt) |
| NO (1) | NO20005418L (pt) |
| NZ (1) | NZ507745A (pt) |
| PL (1) | PL343710A1 (pt) |
| SK (1) | SK16212000A3 (pt) |
| TR (1) | TR200003157T2 (pt) |
| WO (1) | WO1999055372A1 (pt) |
| ZA (1) | ZA200005922B (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6875773B1 (en) | 1998-05-29 | 2005-04-05 | Ben M. Dunn | Combination therapy for treatment of FIV infection |
| EP1146882A2 (en) * | 1998-05-29 | 2001-10-24 | The University Of Florida | Combination of zidovudine (azt) with nucleoside analogs for treatment of feline immunodeficiency virus |
| GB9820417D0 (en) * | 1998-09-18 | 1998-11-11 | Glaxo Group Ltd | Antiviral combinations |
| US7074417B2 (en) * | 2000-10-13 | 2006-07-11 | Advancis Pharmaceutical Corporation | Multiple-delayed release anti-viral product, use and formulation thereof |
| BR0215707A (pt) * | 2002-04-23 | 2005-05-03 | Lupin Ltd | Composição farmacêutica para a liberação controlada de ingredientes ativos e processo para a preparação de uma composição farmacêutica |
| TW200403061A (en) * | 2002-06-04 | 2004-03-01 | Glaxo Group Ltd | Pharmaceutical compositions |
| CN100335125C (zh) * | 2003-06-03 | 2007-09-05 | 上海现代药物制剂工程研究中心 | 杀毒抗菌用长效干扰素喷鼻粉剂 |
| US20110104267A1 (en) * | 2005-04-25 | 2011-05-05 | Aurobindo Pharma Limited | Pharmaceutical compositions of antiretrovirals |
| WO2007013047A2 (en) * | 2005-07-29 | 2007-02-01 | Ranbaxy Laboratories Limited | Water-dispersible anti-retroviral pharmaceutical compositions |
| ES2279707B1 (es) * | 2005-11-10 | 2008-06-01 | Combino Pharm, S.L. | Formulaciones orales que comprenden 3'-azidonucleosidos. |
| CN101878032A (zh) * | 2007-10-02 | 2010-11-03 | 埃默里大学 | 齐多夫定和针对hiv聚合酶中k65r突变选择的药剂的强力组合 |
| GB2470494B (en) * | 2008-01-17 | 2012-08-08 | Univ Holy Ghost Duquesne | Antiretroviral drug formulations for treatment of children exposed to HIV/AIDS |
| SMT201800290T1 (it) * | 2010-01-27 | 2018-07-17 | Viiv Healthcare Co | Terapia antivirale |
| US20130115237A1 (en) | 2010-06-09 | 2013-05-09 | Vaccine Technologies, Incorporated | Therapeutic immunization in hiv infected subjects to augment antiretroviral treatment |
| IN2014MN01907A (pt) | 2012-03-05 | 2015-07-10 | Cipla Ltd | |
| NZ706223A (en) | 2012-10-23 | 2018-11-30 | Cipla Ltd | Pharmaceutical antiretroviral composition |
| SG11201509998WA (en) | 2013-06-13 | 2016-01-28 | Akebia Therapeutics Inc | Compositions and methods for treating anemia |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY115461A (en) * | 1995-03-30 | 2003-06-30 | Wellcome Found | Synergistic combinations of zidovudine, 1592u89 and 3tc |
| GB9622681D0 (en) * | 1996-10-31 | 1997-01-08 | Glaxo Group Ltd | Pharmaceutical compositions |
-
1998
- 1998-04-29 GB GBGB9809213.3A patent/GB9809213D0/en not_active Ceased
-
1999
- 1999-04-26 HR HR20000732A patent/HRP20000732A2/hr not_active Application Discontinuation
- 1999-04-26 EE EEP200000646A patent/EE200000646A/xx unknown
- 1999-04-26 AU AU41355/99A patent/AU4135599A/en not_active Abandoned
- 1999-04-26 CA CA002330391A patent/CA2330391A1/en not_active Abandoned
- 1999-04-26 TR TR2000/03157T patent/TR200003157T2/xx unknown
- 1999-04-26 IL IL13918199A patent/IL139181A0/xx unknown
- 1999-04-26 NZ NZ507745A patent/NZ507745A/en unknown
- 1999-04-26 EP EP99924822A patent/EP1083932A1/en not_active Withdrawn
- 1999-04-26 EA EA200000997A patent/EA200000997A1/ru unknown
- 1999-04-26 PL PL99343710A patent/PL343710A1/xx unknown
- 1999-04-26 ID IDW20002479A patent/ID26955A/id unknown
- 1999-04-26 JP JP2000545569A patent/JP2002512979A/ja active Pending
- 1999-04-26 WO PCT/EP1999/002794 patent/WO1999055372A1/en not_active Ceased
- 1999-04-26 KR KR1020007012021A patent/KR20010043128A/ko not_active Withdrawn
- 1999-04-26 HU HU0101622A patent/HUP0101622A3/hu unknown
- 1999-04-26 CN CN99807983A patent/CN1411380A/zh active Pending
- 1999-04-26 AP APAP/P/2000/001971A patent/AP2000001971A0/en unknown
- 1999-04-26 BR BR9910071-1A patent/BR9910071A/pt not_active IP Right Cessation
- 1999-04-26 SK SK1621-2000A patent/SK16212000A3/sk unknown
-
2000
- 2000-10-20 IS IS5675A patent/IS5675A/is unknown
- 2000-10-23 ZA ZA200005922A patent/ZA200005922B/xx unknown
- 2000-10-27 NO NO20005418A patent/NO20005418L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002512979A (ja) | 2002-05-08 |
| CN1411380A (zh) | 2003-04-16 |
| HUP0101622A3 (en) | 2003-09-29 |
| SK16212000A3 (sk) | 2001-07-10 |
| EA200000997A1 (ru) | 2001-06-25 |
| HRP20000732A2 (en) | 2001-02-28 |
| NO20005418D0 (no) | 2000-10-27 |
| AP2000001971A0 (en) | 2000-12-31 |
| ID26955A (id) | 2001-02-22 |
| HUP0101622A2 (hu) | 2002-03-28 |
| IS5675A (is) | 2000-10-20 |
| NZ507745A (en) | 2004-07-30 |
| IL139181A0 (en) | 2001-11-25 |
| AU4135599A (en) | 1999-11-16 |
| GB9809213D0 (en) | 1998-07-01 |
| EE200000646A (et) | 2002-04-15 |
| NO20005418L (no) | 2000-11-29 |
| PL343710A1 (en) | 2001-08-27 |
| ZA200005922B (en) | 2001-10-23 |
| CA2330391A1 (en) | 1999-11-04 |
| KR20010043128A (ko) | 2001-05-25 |
| BR9910071A (pt) | 2000-12-26 |
| EP1083932A1 (en) | 2001-03-21 |
| WO1999055372A1 (en) | 1999-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200003157T2 (tr) | Abacavir, lamivudin ve zidovudin içeren homojen farmasötik bileşimler | |
| ATE264914T1 (de) | Antivirale proteine, dafür kodierende dna, und deren verwendung | |
| FI20001231A7 (fi) | 2-Deoksi-2,3-didehydro-N-asetyylineuramiinihapon johdannaisia ja niiden analogeja ja niiden käyttö antiviraalisina aineina | |
| DK1126828T3 (da) | Oral indgivelse af adenosin-analoger | |
| MXPA02006679A (es) | Composicion farmaceutica. | |
| NZ333707A (en) | Antiviral compositions comprising Aeginetiae herba derived from plant extracts and at least one other Chinese herbal medicine | |
| BR9811121A (pt) | Produto, composição farmacêutica, e uso de um produto | |
| UA29429C2 (uk) | Фармацевтична композиція для лікування вірусних інфекцій, спосіб отримання композиції, спосіб лікування або профілактики віл-інфекції у людини | |
| BR0210350A (pt) | Nucleosìdeos 4'-substituìdos | |
| RU94013464A (ru) | Нуклеозидные аналоги 1,3-оксатиолана, способ получения, фармацевтическая композиция, способ лечения вирусной инфекции | |
| ES2130114T3 (es) | 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepinas y su uso en la prevencion o tratamiento de infeccion por hiv. | |
| ES2177695T3 (es) | Uso de derivados funcionales de la molecual de adhesion intercelular icam-1 en terapia antiviral. | |
| DE69521693D1 (de) | Taxanderivate enthaltende arzneizubereitungen | |
| DK92788A (da) | Anvendelse af 3'-deoxy-3'-flourguanosider til fremstilling af laegemidler mod retrovira | |
| BR9711647A (pt) | Novos derivados de ácido dicafeoilquìmico, seu uso, composições com os mesmos e métodos de tratamento usando-os. | |
| ES2179110T3 (es) | Succinato 4-(2-amino-6-(ciclopropilamino)-9h-purin-9-il)-2-ciclopenteno-1-metanol como agente antiviral. | |
| EA199900345A1 (ru) | Фармацевтические композиции, содержащие ламивудин и зидовудин | |
| TW371662B (en) | Antiviral acyclic phosphonomethoxyalkyl substituted alkenyl purine and pyrimidine derivatives | |
| IE893991L (en) | 2',3'-dideoxypurine nucleoside/purine nucleoside¹phosphorylase inhibitor combination therapy and composition | |
| PA8449301A1 (es) | Composiciones farmaceuticas | |
| ES2064748T3 (es) | Composiciones antiviricas conteniendo derivados del sulfoquinovosil glicerol y analogos del mismo y su uso. | |
| MX9700044A (es) | Combinacion triple anti-virus de inmunodeficiencia humana. | |
| BR9710206A (pt) | Uso de um agente de interleucina-8 e formulação farmacéutica antiviral | |
| AU7512287A (en) | Expression of human t-cell lymphotropic virus (htlv-iii)reve rse transcriptase and uses thereof | |
| DE69807129D1 (de) | Verwendung einer Kombination von beta-Sitosterol und beta-Sitosterol-Glukosid zur Herstellung eines Medikamentes zur Behandlung von HIV-Infektion |